§

BioCryst Pharmaceuticals, Inc.

No. 77131316 (T.T.A.B. Feb. 8, 2013)
BioCryst Pharmaceuticals, Inc.

5 Cited authorities

  1. In re ECCS, Inc.

    94 F.3d 1578 (Fed. Cir. 1996)   Cited 9 times
    In ECCS, the Federal Circuit was called to determine whether to permit a trademark applicant to amend an admittedly erroneous drawing to conform to its intended trademark, rather than require the trademark be changed to conform to the erroneous drawing.

  2. INSTITUT NAT. DES APPELLATIONS v. VINTNERS

    958 F.2d 1574 (Fed. Cir. 1992)   Cited 13 times
    Affirming finding, on summary judgment, that the term "Chablis" is generic

  3. In re Chemical Dynamics, Inc.

    839 F.2d 1569 (Fed. Cir. 1988)   Cited 14 times
    Concluding that generalized sales and advertising figures do not establish secondary meaning where the alleged mark is not promoted by itself but instead as part of a larger mark or with other designs or marks

  4. In re Hacot-Colombier

    105 F.3d 616 (Fed. Cir. 1997)   Cited 4 times

    No. 96-1240. January 21, 1997. Appealed from: U.S. Patent and Trademark Office Board of Patent Appeals and Interferences. Andrew J. Gray, IV, Jacobson, Price, Holman Stern, P.L.L.C., of Washington, DC, argued, for appellant. With him on the brief was Simor L. Moskowitz. Albin F. Drost, Deputy Solicitor, U.S. Patent and Trademark Office, Arlington, VA, argued, for the Commissioner. With him on the brief were Nancy J. Linck, Solicitor, and Nancy C. Slutter, Associate Solicitor. Of counsel was Kevin

  5. Section 1051 - Application for registration; verification

    15 U.S.C. § 1051   Cited 3,806 times   124 Legal Analyses
    Requiring a filing of a Statement of Use to register a mark